Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

Abstract Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage of heparin. All patients...

Full description

Bibliographic Details
Main Authors: Julie Helms, François Severac, Hamid Merdji, Maleka Schenck, Raphaël Clere-Jehl, Mathieu Baldacini, Mickaël Ohana, Lélia Grunebaum, Vincent Castelain, Eduardo Anglés-Cano, Laurent Sattler, Ferhat Meziani, for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care Sepsis Trial Group for Global EvaluationResearch in Sepsis)
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:Annals of Intensive Care
Subjects:
Anticoagulation
Coagulopathy
COVID-19
Pulmonary embolism
SARS-CoV-2
Thrombosis
Online Access:https://doi.org/10.1186/s13613-021-00809-5

Internet

https://doi.org/10.1186/s13613-021-00809-5

Similar Items